Stevanato Group S.p.A. (STVN)
undefined
undefined%
At close: undefined
23.31
-0.64%
After-hours Dec 13, 2024, 07:00 PM EST

Company Description

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare.

Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.

The company was founded in 1949 and is headquartered in Piombino Dese, Italy.

Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.

Stevanato Group S.p.A.
Stevanato Group S.p.A. logo
Country IT
IPO Date Jul 16, 2021
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 5,635
CEO Franco Stevanato

Contact Details

Address:
Via Molinella, 17
Piombino Dese, PD
IT
Website https://www.stevanatogroup.com

Stock Details

Ticker Symbol STVN
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001849853
CUSIP Number T9224W109
ISIN Number IT0005452658
Employer ID 00-0000000
SIC Code 3221

Key Executives

Name Position
Franco Stevanato Chief Executive Officer & Executive Chairman
Marco Dal Lago Chief Financial Officer
Lisa Miles Chief Communication Officer & Senior Vice President of Investor Relations
Mauro Stocchi Chief Business Officer
Paolo De Fabritiis Chief HR Officer
Riccardo Butta President of Americas
Ugo Gay Chief Operations Officer

Latest SEC Filings

Date Type Title
Nov 14, 2024 SCHEDULE 13G Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 14, 2024 6-K Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 14, 2024 SCHEDULE 13G Filing
Nov 08, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 05, 2024 6-K Filing
Nov 05, 2024 6-K Filing
Nov 05, 2024 6-K Filing